Talenom

Talenom recorded a comparable net sales increase of 2.8% in the second quarter to €30.6m and a comparable EBITDA of €5.8m (margin 18.9%). Finland remained the strongest market with a 30.2% EBITDA margin; Sweden showed lower sales but improved profitability, while Spain grew 26.2% with a negative margin due to integration costs and an impairment. Management confirmed the full-year guidance (net sales €110–120m, comparable EBITDA €18–22m) and intends to advance the software-neutral “ONE Talenom” strategy. The stock fell about 8% in premarket trading to $1.30 as investors criticized the muted growth and the ongoing challenges in Sweden and Spain. » More on de.investing.com

Talenom reported quarterly revenue of EUR 29.6 million for the quarter ended 31.12.2025, an increase of 1.2% compared with the same quarter last year. For the past fiscal year the company reported revenue of EUR 109.11 million, a decline of 13.56% versus the prior year. Earnings per share fell to EUR 0.010 (previous year EUR 0.130). Analysts had expected EUR 0.068 earnings per share and EUR 119.31 million in revenue for the fiscal year, and these expectations were missed. » More on finanzen.net

Talenom will present results for the quarter ended 31 December 2025 on 11 March 2026. Two analysts on average expect earnings per share of -0.011 EUR (prior year 0.000 EUR) and revenue of 27.2 million EUR (−7.05% compared with 29.2 million EUR). For the past fiscal year the analysts on average forecast an EPS of 0.060 EUR (prior year 0.130 EUR) on revenue of 119.2 million EUR (compared with 126.2 million EUR). » More on finanzen.net